Purchases and Sales Made in Q2 2021 in Virpax Pharmaceuticals, Inc. (VRPX)
This table provides information about the institutional ownership of Virpax Pharmaceuticals, Inc. (VRPX) during Q2 2021. The information is specifically focused on institutions that hold shares of Virpax Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Sep 17, 2021
Q2 2021
|
Virtu Financial LLC
New York, NY |
BUY
|
- |
23.6KNew |
$90.7K - $142K
|
23.6K
$9.92K
|
|
|
Aug 13, 2021
Q2 2021
|
Ubs Group Ag
|
BUY
|
- |
962+ 32.28% |
$3.69K - $5.77K
|
3.94K
$1.66K
|
|
|
Aug 16, 2021
Q2 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
11New |
$42.2 - $66
|
11
$4.62
|
|
|
Aug 13, 2021
Q2 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 02, 2021
Q2 2021
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-89Closed |
$342 - $534
|
0
$0
|
|
|
Aug 12, 2021
Q2 2021
|
Saltoro Capital, LP
Dallas, TX |
SELL
|
- |
-9.39K- 34.76% |
$36K - $56.3K
|
17.6K
$7.4K
|
|
|
Aug 16, 2021
Q2 2021
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-45.3K- 22.63% |
$174K - $272K
|
155K
$65K
|